| Nick Corcoran |
Nick Corcoran is currently the Senior Vice President-Supply Chain & Operations at TransMedics Group, Inc. and the Vice President-Division Operations at Stryker Corp. He has a graduate degree from UCD Michael Smurfit Graduate School of Business and an undergraduate degree from South East Technological University. |
| Mark Anderson |
Mark Anderson is currently a Senior Director-Technology Development at TransMedics Group, Inc. He previously worked as a Manager-Research & Development at Teleflex, Inc. Mr. Anderson received his undergraduate degree from Worcester Polytechnic Institute. |
| Laura Damme |
Laura Damme is currently the Vice President-Clinical Affairs at TransMedics Group, Inc. Her former job was as the Director-United States & EMEA Clinical Studies at Thoratec Corp. She completed her undergraduate degree at Grand Valley State University (Michigan) and her graduate degree at the University of Michigan. |
| Phillip Camp |
Phillip Camp is currently the Chief Medical Officer at TransMedics Group, Inc. He previously worked as the Director of Transplant Administration at The Brigham & Women's Hospital, Inc. and as the Medical Director at New England Donor Services. Dr. Camp received his undergraduate degree from the University of Vermont in 1989 and his doctorate from the University of Vermont College of Medicine in 1993. |
| Stephen Gordon |
Stephen Gordon is currently the Chief Financial Officer at TransMedics, Inc. and TransMedics Group, Inc. He previously worked as the Vice President-Financial Planning & Analysis at Analogic Corp. from 2010 to 2015. He also held positions as Principal at Hologic, Inc. and Maxtor Corp. Mr. Gordon holds an MBA from Boston University, which he obtained in 1992. He also has an undergraduate degree from The Wharton School of the University of Pennsylvania, which he received in 1989. |
| Tamer I. Khayal |
Tamer I. Khayal is currently the Chief Medical Officer at TransMedics, Inc. since 2013 and the Chief Commercial Officer at TransMedics Group, Inc. since 2018. Previously, he worked as the Director-Clinical Affairs at Zentiva Group as. Dr. Khayal obtained his doctorate degree from KasrAlAiny School of Medicine in 1993. |
| James R. Tobin |
James R. Tobin is currently the Chairman at TransMedics, Inc., Chairman at TransMedics Group, Inc., Independent Director at Globus Medical, Inc., Director at Impulse Dynamics NV, Lead Independent Director at Lyra Therapeutics, Inc., and Director at Xenter, Inc. Previously, he held positions such as President, Chief Executive Officer & Director at Boston Scientific Corp., President & Chief Executive Officer at Biogen, Inc., Director at Creative Biomolecules, Inc., Director at Applera Corp., Independent Director at Curis, Inc., Director at Medical Simulation Corp., Director at CardioDx, Inc., Director at Aptus Endosystems, Inc., Independent Director at Chiasma, Inc., Independent Non-Executive Director at Oxford Immunotec Global Ltd., Director at Oxford Immunotec Ltd., Director at Biomedical Sciences Careers Program, Inc., Director at Applied Biosystems, Inc., Director at Quest Diagnostics TB LLC, Director at Corindus Vascular Robotics, Inc., Director at Resolys Bio, Inc., President & Chief Operating Officer at Baxter International, Inc., and Principal at US Department of the Navy (District of Columbia). He obtained an MBA from Harvard Business School in 1968 and an undergraduate degree from Harvard College in 1996. |
| Waleed H. Hassanein |
Waleed H. Hassanein is the founder. He founded TransMedics, Inc. in 1998 and currently holds the title of President, Chief Executive Officer & Director. He also founded TransMedics Group, Inc. in 1998 and holds the same title. Dr. Hassanein received his doctorate degree from Georgetown University in 1993. |
| Stephanie Lovell |
Stephanie Lovell is the founder of The New Commonwealth Racial Equity & Social Justice Fund, Inc. She currently holds multiple positions including Director at New England Legal Foundation, Director at The Partnership, Inc., Independent Director at TransMedics Group, Inc., Director at Accompany Health, Inc., Trustee at Massachusetts Taxpayer Foundation, and Assistant Attorney General at Massachusetts Office of The Attorney General. Previously, she served as the Executive Director-State Ethics Commission at State of Massachusetts, Independent Director at Cyclerion Therapeutics, Inc., Senior VP-Administration & General Counsel at Boston Medical Center, and Chief Legal Officer & Executive VP-Medicare at Blue Cross & Blue Shield of Massachusetts, Inc. Ms. Lovell completed her undergraduate degree at Hamilton College (New York) and her graduate degree at Boston University School of Law. |
| Ed M. Kania |
Ed M. Kania is the founder of Flagship Pioneering, which was founded in 1999. He is also the founder of Health Data Analytics Institute, Inc. Mr. Kania's current job titles include Chairman at Vyriad, Inc., Chairman & Managing Partner at Farfield Partners, Director at EcoSense Lighting, Inc., Director at G6 Capital Management LLC, Director at DataCore Software Corp., Director at TransMedics, Inc., Director at Massachusetts Biotechnology Council, Independent Director at TransMedics Group, Inc., and Director at Korrus, Inc. Mr. Kania's former job titles include Chairman at VisEn Medical, Inc., Co-Chairman at Common Impact, Inc., Director at Aspect Medical Systems, Inc., Director at EXACT Sciences Corp., Director at Epitome Biosystems, Inc., Independent Director at Acceleron Pharma, Inc., Director at MedidaMetrics, Inc., Director at INTIO LLC, Director at Interactive Supercomputing, Inc., Director at Pangea DiamondFields Plc, Director at Visterra, Inc., Director at TARIS BioMedical LLC, Independent Director at Selecta Biosciences, Inc., Director at Nanostream, Inc., Director at Oasys Water, Inc., Director at Tarveda Therapeutics, Inc., Managing Partner at One Liberty Ventures, General Partner at Oneliberty Ventures Inc., and Research Associate at Harvard Business School. Mr. Kania's education includes an undergraduate degree from Dartmouth College in 1979 and an MBA from Harvard Business School in 1982. |
| David Weill |
David Weill is currently the Director at TransMedics, Inc., an Independent Director at TransMedics Group, Inc., and the Principal at Weill Consulting Group. Previously, he served as the Director of the Lung & Heart Transplant Program at Stanford University from 2005 to 2016. He also held the position of Director at Stanford Center For Advanced Lung Diseases and Director of the Lung & Heart Lung Transplant Program at Stanford University Medical Center during the same period. Dr. Weill completed his undergraduate degree at Tulane University in 1985 and obtained his doctorate from Tulane University School of Medicine in 1990. |
| Merilee Raines |
Merilee Raines currently works at Watts Water Technologies, Inc., as Independent Director from 2011, Ocular Therapeutix, Inc., as Independent Director from 2021, TransMedics, Inc., as Director, TransMedics Group, Inc., as Independent Director from 2021, and Excelitas Technologies Corp., as Director from 2018. Ms. Raines also formerly worked at Benchmark Electronics, Inc., as Independent Director from 2018 to 2021, Affymetrix, Inc., as Independent Director from 2015 to 2016, Aratana Therapeutics, Inc., as Independent Director from 2014 to 2019, PetVet Care Centers LLC, as Director from 2016 to 2018, Dead River Co., as Director from 2018 to 2021, and IDEXX Laboratories, Inc., as Chief Financial Officer & Executive Vice President from 2012 to 2013. Ms. Raines received her undergraduate degree in 1977 from Bowdoin College and Masters Business Admin degree in 1979 from The University of Chicago. |
| Thomas J. Gunderson |
Thomas J. Gunderson is an Independent Director at Merit Medical Systems, Inc., a Director at TransMedics, Inc., a Director at Abbott Northwestern Hospital Foundation, and an Independent Director at TransMedics Group, Inc. He was formerly the Chairman of Minneapolis Heart Institute Foundation, Inc., a Managing Director & Senior Research Analyst at Piper Sandler & Co. (Broker), and a Project Director at American Medical Systems, Inc. He also served as Vice President-Financial Planning & Analysis at Analogic Corp. Gunderson holds an undergraduate degree from Carleton College, a graduate degree from the University of Minnesota, and an MBA from the University of St. Thomas. |
| Edward M. Basile |
Edward M. Basile is currently a Director at TransMedics, Inc. and an Independent Director at TransMedics Group, Inc. He is also a Member at The Food & Drug Law Institute. Previously, he was the Chairman-FDA & Life Sciences Practice at King & Spalding LLP. He also worked as an Associate Chief Counsel at the US Food & Drug Administration from 1975 to 1985. Additionally, he was a Principal at the Advanced Medical Technology Association. Mr. Basile received his graduate degree from George Washington University in 1972 and his undergraduate degree from Lafayette College in 1969. |
